Rank (Similarity) |
PMID (PMCID) |
|
---|---|---|
21 (43.8%) |
26490523 |
Multicentric Castleman Disease with Monoclonal Incomplete IgH Restriction: A Rare Coexistence. Goyal G, Kendric K, Silberstein PT, Caponetti GC, Vivekanandan R. J Clin Exp Hematop. 2015;55(2):103-8. |
Anemia Fever Lymphadenopathy | ||
IGH | ||
Females Gene Rearrangement HIV Seropositivity Homo sapiens Immunoglobulin Heavy Chains Lymphatic Diseases Middle Aged | ||
21 (43.8%) |
20194090 |
Multicentric Castleman disease: report of rare disease in Kuwait. Mohammad BA, Al-Brahim N, Kunjhibava S, Ahmad M, Ahmad M. Gulf J Oncolog. 2009;(6):48-50. |
Anemia Fever Follicular hyperplasia | ||
Homo sapiens Male Middle Aged | ||
21 (43.8%) |
1542967 |
[Angiofollicular lymph node hyperplasia (Castleman disease)]. Pedersen LM, Nielsen H. Ugeskr Laeger. 1992;154(10):621-4. |
Anemia Fever Lymphadenopathy | ||
Differential Diagnosis Homo sapiens Male Middle Aged | ||
24 (40.3%) |
17616028 (2687612) |
Castleman disease presenting with jaundice: a case with the multicentric hyaline vascular variant. Park JB, Hwang JH, Kim H, Choe HS, Kim YK, Kim HB, Bang SM. Korean J Intern Med. 2007;22(2):113-7. |
Jaundice Lymphadenopathy Lymphoproliferative disorder | ||
Abdominal Pain Adrenal Cortex Hormones Biopsy Homo sapiens Icterus Male Middle Aged Positron-Emission Tomography Vascular Diseases X-Ray Computed Tomography | ||
25 (39.6%) |
31253137 |
Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report. Li P, Liu H, Li H, Li A, Yu G, Yin W. Diagn Pathol. 2019;14(1):70. |
Plethora Follicular hyperplasia Lymphoproliferative disorder | ||
Adult Differential Diagnosis Homo sapiens Hyalin Substance Immunohistochemistry Lymphocyte Lymphoid Tissue Lymphoproliferative Disorders Male Palatine Tonsil | ||
26 (38.8%) |
30009125 (6038051) |
Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage. Noda Y, Saka Y, Kato A, Mimura T, Naruse T. Clin Nephrol Case Stud. 2018;6:16-20. |
Edema Ascites Thrombocytopenia | ||
26 (38.8%) |
28367597 |
Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases. Zhou X, Wei J, Lou Y, Xu G, Yang M, Liu H, Mao L, Tong H, Jin J. Front Med. 2017;11(2):287-292. |
Ascites Pleural effusion Lymphoproliferative disorder | ||
Adult Combined Modality Therapy Homo sapiens Male Middle Aged Remission Induction Salvage Therapy Transplantation, Autologous Young Adult | ||
28 (37.6%) |
30235674 (6160051) |
Castleman disease mimicking systemic lupus erythematosus: A case report. Wang L, Chen H, Shi J, Tang H, Li H, Zheng W, Zhang F. Medicine (Baltimore). 2018;97(38):e12291. |
Proteinuria Glomerulonephritis Anemia | ||
DDIT3 | ||
Anemia Differential Diagnosis Fever Glomerulonephritis, Membranoproliferative Homo sapiens Lupus Erythematosus, Systemic Male Middle Aged Nephrotic Syndrome Serositis Thrombocytopenia | ||
28 (37.6%) |
26387507 |
Anemia and autoimmunity markers in an adolescent with Castleman disease. Fretzayas A, Stasinopoulou A, Moustaki M, Stefos E, Kaniouras G, Nicolaidou P. Pediatr Int. 2015;57(6):1199-201. |
Anemia Autoimmunity Low-grade fever | ||
IL6 | ||
Anemia Biological Markers Differential Diagnosis Females Homo sapiens Magnetic Resonance Imaging Positron-Emission Tomography X-Ray Computed Tomography | ||
30 (37.6%) |
24367988 |
Iron-refractory microcytic anemia as the presenting feature of unicentric Castleman disease in children. Chandrakasan S, Bakeer N, Mo JQ, Cost C, Quinn CT. J Pediatr. 2014;164(4):928-30. |
Anemia Lymphadenopathy | ||
Child Females Homo sapiens |
Total: 29
HPO ID | Term | Frequency |
---|---|---|
HP:0002716 | Lymphadenopathy | Very frequent (99-80%) |
HP:0001824 | Weight loss | Frequent (79-30%) |
HP:0001903 | Anemia | Frequent (79-30%) |
HP:0002027 | Abdominal pain | Frequent (79-30%) |
HP:0002729 | Follicular hyperplasia | Frequent (79-30%) |
HP:0003565 | Elevated erythrocyte sedimentation rate | Frequent (79-30%) |
HP:0011227 | Elevated C-reactive protein level | Frequent (79-30%) |
HP:0012378 | Fatigue | Frequent (79-30%) |
HP:0025142 | Constitutional symptom | Frequent (79-30%) |
HP:0030783 | Increased serum interleukin-6 | Frequent (79-30%) |
HP:0100721 | Mediastinal lymphadenopathy | Frequent (79-30%) |
HP:0000952 | Jaundice | Occasional (29-5%) |
HP:0002017 | Nausea and vomiting | Occasional (29-5%) |
HP:0003270 | Abdominal distention | Occasional (29-5%) |
HP:0008940 | Generalized lymphadenopathy | Occasional (29-5%) |
HP:0011024 | Abnormality of the gastrointestinal tract | Occasional (29-5%) |
HP:0012735 | Cough | Occasional (29-5%) |
HP:0025066 | Decreased mean corpuscular volume | Occasional (29-5%) |
HP:0030157 | Flank pain | Occasional (29-5%) |
HP:0031500 | Abdominal mass | Occasional (29-5%) |
HP:0000083 | Renal insufficiency | Very rare (4-1%) |
HP:0000790 | Hematuria | Very rare (4-1%) |
HP:0001723 | Restrictive cardiomyopathy | Very rare (4-1%) |
HP:0001873 | Thrombocytopenia | Very rare (4-1%) |
HP:0002094 | Dyspnea | Very rare (4-1%) |
HP:0005214 | Intestinal obstruction | Very rare (4-1%) |
HP:0006000 | Ureteral obstruction | Very rare (4-1%) |
HP:0011974 | Myelofibrosis | Very rare (4-1%) |
HP:0012050 | Anasarca | Very rare (4-1%) |
Total: 63
HPO ID | Term | # of case reports |
---|---|---|
HP:0005523 | Lymphoproliferative disorder | 36 |
HP:0002716 | Lymphadenopathy | 8 |
HP:0001271 | Polyneuropathy | 7 |
HP:0030731 | Carcinoma | 7 |
HP:0002664 | Neoplasm | 5 |
HP:0001945 | Fever | 4 |
HP:0002721 | Immunodeficiency | 4 |
HP:0030150 | Plasmacytosis | 4 |
HP:0000969 | Edema | 3 |
HP:0001744 | Splenomegaly | 3 |
HP:0001903 | Anemia | 3 |
HP:0031501 | Pelvic mass | 3 |
HP:0100242 | Sarcoma | 3 |
HP:0001028 | Hemangioma | 2 |
HP:0001433 | Hepatosplenomegaly | 2 |
HP:0001891 | Iron deficiency anemia | 2 |
HP:0002729 | Follicular hyperplasia | 2 |
HP:0008940 | Generalized lymphadenopathy | 2 |
HP:0011974 | Myelofibrosis | 2 |
HP:0031500 | Abdominal mass | 2 |
HP:0000100 | Nephrotic syndrome | 1 |
HP:0000112 | Nephropathy | 1 |
HP:0000135 | Hypogonadism | 1 |
HP:0000572 | Visual loss | 1 |
HP:0000790 | Hematuria | 1 |
HP:0000819 | Diabetes mellitus | 1 |
HP:0000821 | Hypothyroidism | 1 |
HP:0000846 | Adrenal insufficiency | 1 |
HP:0000952 | Jaundice | 1 |
HP:0001138 | Optic neuropathy | 1 |
HP:0001370 | Rheumatoid arthritis | 1 |
HP:0001541 | Ascites | 1 |
HP:0001873 | Thrombocytopenia | 1 |
HP:0001894 | Thrombocytosis | 1 |
HP:0001909 | Leukemia | 1 |
HP:0001935 | Microcytic anemia | 1 |
HP:0001955 | Unexplained fevers | 1 |
HP:0002024 | Malabsorption | 1 |
HP:0002027 | Abdominal pain | 1 |
HP:0002094 | Dyspnea | 1 |
HP:0002617 | Dilatation | 1 |
HP:0002668 | Paraganglioma | 1 |
HP:0002835 | Aspiration | 1 |
HP:0002960 | Autoimmunity | 1 |
HP:0003072 | Hypercalcemia | 1 |
HP:0003073 | Hypoalbuminemia | 1 |
HP:0003418 | Back pain | 1 |
HP:0005200 | Retroperitoneal fibrosis | 1 |
HP:0005521 | Disseminated intravascular coagulation | 1 |
HP:0009830 | Peripheral neuropathy | 1 |
HP:0010280 | Stomatitis | 1 |
HP:0011134 | Low-grade fever | 1 |
HP:0011506 | Choroidal neovascularization | 1 |
HP:0011510 | Drusen | 1 |
HP:0011946 | Bronchiolitis obliterans | 1 |
HP:0012050 | Anasarca | 1 |
HP:0012432 | Chronic fatigue | 1 |
HP:0012593 | Nephrotic range proteinuria | 1 |
HP:0025289 | Cervical lymphadenopathy | 1 |
HP:0032046 | Focal cortical dysplasia | 1 |
HP:0100008 | Schwannoma | 1 |
HP:0100632 | Pulmonary sequestration | 1 |
HP:0100726 | Kaposi's sarcoma | 1 |
Total: 0
Gene Symbol | Gene Name | Entrez Gene ID |
---|